Mehdi Aliomrani

633 total citations
44 papers, 499 citations indexed

About

Mehdi Aliomrani is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Pharmacology. According to data from OpenAlex, Mehdi Aliomrani has authored 44 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 10 papers in Pathology and Forensic Medicine and 7 papers in Pharmacology. Recurrent topics in Mehdi Aliomrani's work include Multiple Sclerosis Research Studies (9 papers), Heavy Metal Exposure and Toxicity (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Mehdi Aliomrani is often cited by papers focused on Multiple Sclerosis Research Studies (9 papers), Heavy Metal Exposure and Toxicity (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Mehdi Aliomrani collaborates with scholars based in Iran, Canada and Germany. Mehdi Aliomrani's co-authors include Mohammad Reza Sepand, Hamid Shirkhanloo, Mohammad Ali Sahraian, Mina Mirian, Jaleh Varshosaz, Mohammad Reza Khoshayand, Mohammad Sharifzadeh, Ali Kazemi, Omid Sabzevari and Hamid Reza Mirzaei and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Pharmaceutics and International Journal of Biological Macromolecules.

In The Last Decade

Mehdi Aliomrani

42 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mehdi Aliomrani Iran 13 175 105 78 72 64 44 499
Leila Zeidooni Iran 14 110 0.6× 148 1.4× 44 0.6× 51 0.7× 40 0.6× 34 487
Darakhshan Javaid India 5 222 1.3× 74 0.7× 105 1.3× 29 0.4× 40 0.6× 11 678
Shahid Yousuf Ganie India 5 223 1.3× 71 0.7× 104 1.3× 29 0.4× 40 0.6× 11 676
Guangwei Xing China 15 307 1.8× 146 1.4× 116 1.5× 46 0.6× 34 0.5× 41 659
Vadavanath Prabhakaran Vineetha India 14 206 1.2× 46 0.4× 74 0.9× 34 0.5× 31 0.5× 31 546
Pallab Shaw India 12 381 2.2× 260 2.5× 51 0.7× 37 0.5× 36 0.6× 26 896
Khalid S. Hashem Egypt 15 137 0.8× 171 1.6× 125 1.6× 74 1.0× 40 0.6× 30 777
Qinli Ruan China 13 170 1.0× 49 0.5× 84 1.1× 30 0.4× 35 0.5× 28 507
Kuo‐Liang Chen Taiwan 10 177 1.0× 158 1.5× 71 0.9× 17 0.2× 31 0.5× 22 581
Kiruthika Sundarraj India 12 501 2.9× 65 0.6× 89 1.1× 55 0.8× 100 1.6× 12 889

Countries citing papers authored by Mehdi Aliomrani

Since Specialization
Citations

This map shows the geographic impact of Mehdi Aliomrani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehdi Aliomrani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehdi Aliomrani more than expected).

Fields of papers citing papers by Mehdi Aliomrani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mehdi Aliomrani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehdi Aliomrani. The network helps show where Mehdi Aliomrani may publish in the future.

Co-authorship network of co-authors of Mehdi Aliomrani

This figure shows the co-authorship network connecting the top 25 collaborators of Mehdi Aliomrani. A scholar is included among the top collaborators of Mehdi Aliomrani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mehdi Aliomrani. Mehdi Aliomrani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aliomrani, Mehdi, et al.. (2025). Preparation and evaluation of pomegranate seed oil nanoemulsions for delivery of fingolimod hydrochloride in multiple sclerosis treatment. Journal of Drug Delivery Science and Technology. 114. 107541–107541.
2.
Haddadi, Fatemeh, et al.. (2025). Preparation and In vitro/In vivo Evaluation of Fingolimod hydrochloride Loaded Polymeric Mixed Nano-Micelles for Treatment of Multiple Sclerosis. Journal of Neuroimmune Pharmacology. 20(1). 41–41. 1 indexed citations
3.
Varshosaz, Jaleh, et al.. (2024). Polydopamine coated surfactin micelles for brain delivery of ibudilast in multiple sclerosis: Design, optimization, in vitro and in vivo evaluation. Journal of Drug Delivery Science and Technology. 95. 105530–105530. 4 indexed citations
4.
5.
Varshosaz, Jaleh, et al.. (2023). Nose to brain delivery of ibudilast micelles for treatment of multiple sclerosis in an experimental autoimmune encephalomyelitis animal model. International Journal of Pharmaceutics. 638. 122936–122936. 8 indexed citations
6.
Aliomrani, Mehdi, et al.. (2023). Cyclotide nanotubes as a novel potential Drug-Delivery System: Characterization and biocompatibility. International Journal of Pharmaceutics. 642. 123104–123104. 5 indexed citations
7.
Aliomrani, Mehdi, et al.. (2023). Perfluorooctanoic acid exposure and its neurodegenerative consequences in C57BL6/J mice. Naunyn-Schmiedeberg s Archives of Pharmacology. 396(10). 2357–2367. 3 indexed citations
8.
9.
Aliomrani, Mehdi, et al.. (2022). Copper‐Curcumin‐Bipyridine Dicarboxylate Complexes as Anticancer Candidates. Chemistry & Biodiversity. 19(10). e202200202–e202200202. 9 indexed citations
10.
Varshosaz, Jaleh, et al.. (2022). Morphological studies of self-assembled cyclotides extracted fromViola odorataas novel versatile platforms in biomedical applications. Biomaterials Science. 10(18). 5172–5186. 1 indexed citations
11.
Pourfarzam, Morteza, et al.. (2022). Effect of pretreatment with a synbiotic on Perfluorooctanoic acid-induced liver damage after sub-acute oral exposure in C57BL/6J mice. Toxicology and Applied Pharmacology. 459. 116360–116360. 5 indexed citations
12.
Aliomrani, Mehdi, et al.. (2022). Involvement of Mice Hippocampus Brain-derived Neurotrophic Factor in Diazinon-induced Depressive Behavior in Mice. Iranian Journal of Toxicology. 16(2). 125–134. 1 indexed citations
13.
Akbari, Vajihe, et al.. (2021). Risk of neurodegenerative disease due to tau phosphorylation changes and arsenic exposure via drinking water. Toxicology Research. 10(2). 325–333. 23 indexed citations
14.
15.
Sepand, Mohammad Reza, et al.. (2020). Mechanisms and pathogenesis underlying environmental chemical-induced necroptosis. Environmental Science and Pollution Research. 27(30). 37488–37501. 34 indexed citations
16.
Mirian, Mina, et al.. (2020). Apamin administration impact on miR-219 and miR-155-3p expression in cuprizone induced multiple sclerosis model. Molecular Biology Reports. 47(11). 9013–9019. 13 indexed citations
17.
Aliomrani, Mehdi, et al.. (2019). The Prevalence of the Genetic Polymorphism of GSTM1, GSTT1 and GSTP1 and Its Relationship with Clinical Criteria of Multiple Sclerosis (MS) Patients in Tehran. SHILAP Revista de lepidopterología. 3 indexed citations
18.
Jahanian‐Najafabadi, Ali, et al.. (2018). Chronic Oral Arsenic Exposure and Its Correlation with Serum S100B Concentration. Biological Trace Element Research. 189(1). 172–179. 19 indexed citations
19.
Razavi-Azarkhiavi, Kamal, et al.. (2014). Silymarin alleviates bleomycin-induced pulmonary toxicity and lipid peroxidation in mice. Pharmaceutical Biology. 52(10). 1267–1271. 38 indexed citations
20.
Aliomrani, Mehdi, Abbas Jafarian‐Dehkordi, & Behzad Zolfaghari. (2012). Cytotoxicity of Euphorbia bungei on HeLa and HT29 tumor cells. Research in Pharmaceutical Sciences. 7(5). 130. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leila Zeidooni Breakdown of academic impact, for papers by Darakhshan Javaid Breakdown of academic impact, for papers by Shahid Yousuf Ganie Breakdown of academic impact, for papers by Guangwei Xing Breakdown of academic impact, for papers by Vadavanath Prabhakaran Vineetha Breakdown of academic impact, for papers by Pallab Shaw Breakdown of academic impact, for papers by Khalid S. Hashem Breakdown of academic impact, for papers by Qinli Ruan Breakdown of academic impact, for papers by Kuo‐Liang Chen Breakdown of academic impact, for papers by Kiruthika Sundarraj
Rankless by CCL
2026